This study demonstrates that the non-invasive assessment of SPIO contrast agent uptake in vivo using high field MRI can be used as a marker of macrophage activity during the early stages of ANG II-induced AAA in apoE−/−mice. This evidence concerns the gene APOE and triple-A syndrome.